High-dose treatment of cathepsin B-activatable doxorubicin prodrug nanoparticles that induce tumor-specific immunogenic cell death for immunotherapy of melanoma with minimal systemic toxicity
Asian J. Pharm. Sci., Available online 13 January 2026 | https://doi.org/10.1016/j.ajps.2026.101123
The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis
Biomaterials, Available online 19 October 2021, 121189 | https://doi.org/10.1016/j.biomaterials.2021.121189
![[CN Bio / Fluigent / 신코] Organ on a Chip 플랫폼 & ICP 등 바이오 연구장비 라인업](/app/board/attach/image/1348946_1772523445000.do?)
